FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCI2NA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
Study of terbium production from enriched Gd targets via the reaction 155Gd(d,2n)155Tb, Wang Y, Sounalet T, Guertin A, Nigron E, Michel N, Haddad F, Applied Radiation and Isotopes. nov 2023;201:110996. https://doi.org/10.1016/j.apradiso.2023.110996
Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction ?, Nigron E, Guertin A, Haddad F, Granger L, Rayer M, Rintaud A, Applied Radiation and Isotopes. juill 2023;110927. https://doi.org/10.1016/j.apradiso.2023.110927
our news
The Mooc “At the heart of European medical radioactivity” is now open!
27/09/23
A new radiopharmaceutical production room at Arronax
11/09/23
ISI NucMed 2023: Confirmed success for Nantes’ thematic school in nuclear medicine
19/07/23
« The community around astatine 211 is booming »
28/06/23![[Agenda] NET Symposium of RHU OPERANDI on neuroendocrine tumours](/wp-content/uploads/2023/05/logo-RHU_OPERANDI-270x200.png){kind=logo}
[Agenda] NET Symposium of RHU OPERANDI on neuroendocrine tumours
24/05/23
Keerthana Kamalakannan’s work awarded at ARCEBS 2023
03/05/23Our equipments
